1997
DOI: 10.1111/j.1360-0443.1997.tb03373.x
|View full text |Cite
|
Sign up to set email alerts
|

Mortality and survival among a cohort of drug injectors in Glasgow, 1982–1994

Abstract: There has been much speculation about the nature and extent of mortality among drug injectors in Glasgow. In order to determine injectors' mortality rate and compare this rate to the general population, identifier information from 459 drug injectors who received treatment for drug misuse in Glasgow between 1982 and 1994 was linked to the Scottish Mortality Register. The average duration of follow-up from cohort entry was 5.5 years and 10.2 years from commencement of drug injection. By the end of 1994, 53 cohor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
31
0

Year Published

2000
2000
2020
2020

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 111 publications
(31 citation statements)
references
References 14 publications
0
31
0
Order By: Relevance
“…Approximately 60–70% of drug users experience an overdose during their lifetime (Sergeev et al, 2003; Warner-Smith et al, 2002). Drug users have mortality rates 6.9–22.0 times greater than rates among the general population (Frischer et al, 1997; Hulse et al, 1999; Joe and Simpson, 1987), and much of this excess mortality is attributable to drug overdose. In New York City (NYC), drug overdose is a significant problem; in 2007 death due to drug use and accidental overdose was the third leading cause of death among residents aged 15–34, and the fourth leading cause of death among residents aged 35–54 (NYC Bureau of Vital Statistics, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Approximately 60–70% of drug users experience an overdose during their lifetime (Sergeev et al, 2003; Warner-Smith et al, 2002). Drug users have mortality rates 6.9–22.0 times greater than rates among the general population (Frischer et al, 1997; Hulse et al, 1999; Joe and Simpson, 1987), and much of this excess mortality is attributable to drug overdose. In New York City (NYC), drug overdose is a significant problem; in 2007 death due to drug use and accidental overdose was the third leading cause of death among residents aged 15–34, and the fourth leading cause of death among residents aged 35–54 (NYC Bureau of Vital Statistics, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…The mortality was particularly high among those treated for opioid poisonings (SMR 29). Although they were not identical cohorts, the SMRs among those poisoned by opioids were similar to those of intravenous drug users in Glasgow, Scotland (SMR 22) and heroin addicts in Catalonia, Spain (SMR 29) [12,13]. A higher proportion of the patients treated in hospital for opioid poisoning died, but the SMR was lower in this cohort, which reflected their older age.…”
Section: Discussionmentioning
confidence: 69%
“…Of note, we assume SVR does not benefit PWID apropos risk of reinfection and the subsequent chance of spontaneous clearance. Finally, at every stage of the model, death from non-liver-related causes occurs at a rate of 1.8%33 and 1.4% per annum, in PWID and former/never PWID states, respectively (see online supplementary appendix D regarding estimation of the latter mortality rate).…”
Section: Methodsmentioning
confidence: 99%